menu
    • menu

    Company profile for Axcella Health

    NEW Drugs in Dev: 4
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a biotechnology company pioneering the research and development of novel multifactorial interventions to support health and address dysregulated metabolism across a broad spectrum of consumers, and patients who have limited options. Our AXA Candidates are generated from our proprietary, human‑focused AXA Development Platform* and harness the power of endogenous metabolic modulators, or EMMs, a broad family of molecule...
    We are a biotechnology company pioneering the research and development of novel multifactorial interventions to support health and address dysregulated metabolism across a broad spectrum of consumers, and patients who have limited options. Our AXA Candidates are generated from our proprietary, human‑focused AXA Development Platform* and harness the power of endogenous metabolic modulators, or EMMs, a broad family of molecules that fundamentally impact and regulate human metabolism. Using our AXA Development Platform, we have rapidly generated a pipeline of AXA Candidates that are novel compositions of EMMs engineered in distinct ratios .

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Axcella HealthUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    840 Memorial Drive, Cambridge, MA 02139 Entrance on Blackstone Street | Third ...
    Telephone
    Telephone
    857-320-2200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://axcellatx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/axcella-tx
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Flagship-founded Axcella folds
    Flagship-founded Axcella folds

    05 Dec 2023

    // Gabrielle Masson FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/axcella-gets-ax-flagship-founded-biotech-closes-its-doors-after-12-year-run

    Gabrielle Masson FIERCE BIOTECH
    05 Dec 2023
    Share Share
    Axcella Announces Reverse Stock Split Effective September 19, 2023
    Axcella Announces Reverse Stock Split Effective September 19, 2023

    14 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230914273546/en

    BUSINESSWIRE
    14 Sep 2023
    Share Share
    Axcella Granted Patent for Long COVID Fatigue Treatment
    Axcella Granted Patent for Long COVID Fatigue Treatment

    29 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230829372113/en

    BUSINESSWIRE
    29 Aug 2023
    Share Share
    Axcella Reports Second Quarter Financial Results and Provides Business Update
    Axcella Reports Second Quarter Financial Results and Provides Business Update

    03 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230803884578/en

    BUSINESSWIRE
    03 Aug 2023
    Share Share
    Axcella Reports First Quarter Financial Results and Provides Business Update
    Axcella Reports First Quarter Financial Results and Provides Business Update

    04 May 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230504006005/en

    BUSINESSWIRE
    04 May 2023
    Share Share
    Axcella Reports 4Q and Full Reports Full 2022 FYR and Provides Business Update
    Axcella Reports 4Q and Full Reports Full 2022 FYR and Provides Business Update

    30 Mar 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230330005233/en

    BUSINESSWIRE
    30 Mar 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search